21 results on '"Piris, M. A."'
Search Results
2. Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma
3. Toll-like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation
4. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation
5. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas
6. Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
7. B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies
8. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
9. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
10. Lack and/or aberrant localization of major histocompatibility class II (MHCII) protein in plasmablastic lymphoma
11. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
12. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas
13. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype
14. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features
15. The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
16. Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
17. Expression pattern of XBP1(S) in human B-cell lymphomas
18. Somatic hypermutation signature in B-cell low-grade lymphomas
19. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia
20. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
21. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.